Payment overview · 2025
General Payments
$116,008.66
262 reported records · 24 companies
Healthcare provider profile · identity verified
Adel Barkat, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · TULSA, OK · NPI 1467776476
Verified facts
What the public records show
CMS Open Payments records show Adel Barkat, M.D. received $116,008.66 in general payments during 2025 across 262 reported records.
Penumbra, Inc. accounted for 64.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 53 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 57 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $74,344.91 | 64.1% | 51 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $21,127.51 | 18.2% | 15 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $5,822.61 | 5.0% | 5 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $4,181.31 | 3.6% | 28 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $2,496.32 | 2.1% | 42 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$2,298.17 | 2.0% | 44 | 2025 |
| CENTERLINE BIOMEDICAL INC. | Unresolved — no canonical attribution shown | $1,116.58 | 1.0% | 2 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $975.83 | 0.8% | 14 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $897.91 | 0.8% | 10 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $758.61 | 0.7% | 8 | 2025 |
| Baxter Healthcare | Unresolved — no canonical attribution shown | $473.05 | 0.4% | 8 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $257.03 | 0.2% | 2 | 2025 |
| Nalu Medical, Inc. | Unresolved — no canonical attribution shown | $223.97 | 0.2% | 3 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $220.09 | 0.2% | 3 | 2025 |
| Shape Memory Medical Inc. | Unresolved — no canonical attribution shown | $181.27 | 0.2% | 3 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $143.75 | 0.1% | 7 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $124.40 | 0.1% | 1 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $104.85 | 0.1% | 5 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $66.97 | 0.1% | 2 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $57.56 | 0.1% | 4 | 2025 |
| CVRx, Inc. | Unresolved — no canonical attribution shown | $49.36 | 0.0% | 1 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $34.82 | 0.0% | 1 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $26.92 | 0.0% | 2 | 2025 |
| Acera Surgical, Inc. | Unresolved — no canonical attribution shown | $24.86 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,725.00 | 16 |
| Travel and Lodging | $32,783.27 | 20 |
| Food and Beverage | $15,375.39 | 222 |
| Consulting Fee | $11,125.00 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $70,617.91 | 49 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $20,662.77 | 10 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $5,822.61 | 5 | 2025 |
Source payment records
|
|||||
| RUBY Coil Normalized: ruby coil |
Device | Penumbra, Inc. | $3,600.00 | 1 | 2025 |
Source payment records
|
|||||
| ANGIOVAC Normalized: angiovac |
Device | AngioDynamics, Inc. | $2,659.92 | 2 | 2025 |
Source payment records
|
|||||
| ALPHAVAC Normalized: alphavac |
Device | AngioDynamics, Inc. | $1,444.54 | 24 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $1,440.07 | 33 | 2025 |
Source payment records
|
|||||
| IOPS Normalized: iops |
Device | CENTERLINE BIOMEDICAL INC. | $1,116.58 | 2 | 2025 |
Source payment records
|
|||||
| IOPS MOBILE CART Normalized: iops mobile cart |
Device | CENTERLINE BIOMEDICAL INC. | $1,116.58 | 2 | 2025 |
Source payment records
|
|||||
| IOPS SOFTWARE APPLICATION Normalized: iops software application |
Device | CENTERLINE BIOMEDICAL INC. | $1,116.58 | 2 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $975.83 | 14 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $754.85 | 9 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $745.78 | 7 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $745.78 | 7 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $558.10 | 4 | 2025 |
Source payment records
|
|||||
| VALIANT CAPTIVIA Normalized: valiant captivia |
Device | Medtronic, Inc. | $369.57 | 6 | 2025 |
Source payment records
|
|||||
| HAWKONE Normalized: hawkone |
Device | Medtronic, Inc. | $301.14 | 3 | 2025 |
Source payment records
|
|||||
| FLOSEAL Normalized: floseal |
Biological | Baxter Healthcare | $273.60 | 3 | 2025 |
Source payment records
|
|||||
| Nalu Neurostimulation System Normalized: nalu neurostimulation system |
Device | Nalu Medical, Inc. | $223.97 | 3 | 2025 |
Source payment records
|
|||||
| PREVELEAK Normalized: preveleak |
Device | Baxter Healthcare | $199.45 | 5 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $196.43 | 2 | 2025 |
Source payment records
|
|||||
| IMPEDE EMBOLIZATION PLUG Normalized: impede embolization plug |
Device | Shape Memory Medical Inc. | $181.27 | 3 | 2025 |
Source payment records
|
|||||
| HELI-FX ENDOANCHOR SYSTEM Normalized: heli fx endoanchor system |
Device | Medtronic, Inc. | $173.87 | 1 | 2025 |
Source payment records
|
|||||
| THORAFLEX HYBRID Normalized: thoraflex hybrid |
Device | Bolton Medical Inc | $159.48 | 1 | 2025 |
Source payment records
|
|||||
| XACT Normalized: xact |
Device | Abbott Laboratories | $143.06 | 1 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $134.99 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $127.00 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $124.40 | 1 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $114.49 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | E.R. Squibb & Sons, L.L.C. | $104.85 | 5 | 2025 |
Source payment records
|
|||||
| ENHANCE Transcarotid Peripheral Access Kit Normalized: enhance transcarotid peripheral access kit |
Device | Boston Scientific Corporation | $104.13 | 1 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Endoprosthesis Normalized: gore tag conformable thoracic endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $77.50 | 4 | 2025 |
Source payment records
|
|||||
| MICRO ACCESS Normalized: micro access |
Device | AngioDynamics, Inc. | $76.85 | 2 | 2025 |
Source payment records
|
|||||
| General - Endovascular Aortic Repair Normalized: general endovascular aortic repair |
Device | Boston Scientific Corporation | $60.51 | 1 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $50.62 | 1 | 2025 |
Source payment records
|
|||||
| Barostim Neo System Normalized: barostim neo system |
Device | CVRx, Inc. | $49.36 | 1 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $45.00 | 2 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $43.84 | 3 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $43.84 | 3 | 2025 |
Source payment records
|
|||||
| MITRIS RESILIA Mitral Valve Normalized: mitris resilia mitral valve |
Device | Edwards Lifesciences Corporation | $36.50 | 1 | 2025 |
Source payment records
|
|||||
| ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Normalized: atricure cryoice cryosphere cryoablation system |
Device | AtriCure, Inc. | $34.82 | 1 | 2025 |
Source payment records
|
|||||
| KONECT RESILIA Normalized: konect resilia |
Device | Edwards Lifesciences Corporation | $30.47 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $26.92 | 2 | 2025 |
Source payment records
|
|||||
| Restrata Wound Matrix Normalized: restrata wound matrix |
Device | Acera Surgical, Inc. | $24.86 | 1 | 2025 |
Source payment records
|
|||||
| PRODIGY CATHETER Normalized: prodigy catheter |
Device | Imperative Care, Inc | $23.66 | 1 | 2025 |
Source payment records
|
|||||
| GORE TAG Conformable Thoracic Stent Graft Normalized: gore tag conformable thoracic stent graft |
Device | W. L. Gore & Associates, Inc. | $21.25 | 1 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $13.72 | 1 | 2025 |
Source payment records
|
|||||
| CLOSUREFAST Normalized: closurefast |
Device | Medtronic, Inc. | $13.52 | 1 | 2025 |
Source payment records
|
|||||
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $12.83 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $12.49 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $12.49 | 1 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $12.49 | 1 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $12.49 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 57 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
57 | 17 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 356 | 99 |
| Xarelto | Rivaroxaban | 67 | 21 |
| Eliquis | Apixaban | 57 | 17 |
| Atorvastatin Calcium | Atorvastatin Calcium | 37 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 21 |
| Prednisone | Prednisone | 22 | 16 |
| Famotidine | Famotidine | 21 | 17 |
| Brilinta | Ticagrelor | 16 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $116,008.66 · 262 records | Penumbra, Inc. | AFX2 Bifurcated Endograft System, ALPHAVAC, ANGIOVAC, ARTIX MT, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, Barostim Neo System, CLOSUREFAST, CT THROMBECTOMY SYSTEM KIT, ELIQUIS, ELUVIA, ENDOCROSS Device, ENDURANT IIS, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE Transcarotid Neuroprotection System, ESPRIT, FLOSEAL, FLOWTRIEVER CATHETER, S, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE TAG Conformable Thoracic Endoprosthesis, GORE TAG Conformable Thoracic Stent Graft, General - Endovascular Aortic Repair, General - Therapies, General - Vascular Intervention, HAWKONE, HELI-FX ENDOANCHOR SYSTEM, IMPEDE EMBOLIZATION PLUG, IOPS, IOPS MOBILE CART, IOPS SOFTWARE APPLICATION, Indigo System, KONECT RESILIA, MICRO ACCESS, MITRIS RESILIA Mitral Valve, Nalu Neurostimulation System, PREVELEAK, PRODIGY CATHETER, Penumbra System, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, RUBY Coil, Restrata Wound Matrix, SYMPHONY CATHETER, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, THORAFLEX HYBRID, TREO ABDOMINAL STENT-GRAFT SYSTEM, Torus Stent Graft System, VALIANT CAPTIVIA, XACT, ZILVER PTX | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error